Under today's deal, all of UC Health's medical centers will work with GeneDx and have access to more than 400 of the firm's tests for rare hereditary disorders.
Diaceutics will use the data to help its pharmaceutical industry clients speed their rollouts of new cancer drugs.
Going forward, Natera said it will market its Panorama NIPT assay and carrier screening test Horizon directly to physicians.
Around 16,000 4Kscore prostate cancer tests were performed in Q3, which is a 365 percent increase over Q3 2015.
Experts said that the EMR is a crucial channel for aggregating clinical insights from multiple sources, but plenty of work is needed to achieve broader adoption.
The company, which is part of Opko Health's BioReference Laboratories, recently hired a new managing director, who plans to expand the firm's market and testing portfolio.
The two entities also plan to work together using the data generated from the tests to do added research.
The performance of WES for genetically heterogeneous disorders improves significantly when testing is performed on the proband and two or more family members.
The partners will develop an NGS panel for solid and liquid tumors for use in personalized oncology.
The company joins the Pistoia Alliance as a participating member and the Global Alliance for Genomics and Health as an organizational member.
A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.
The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.
In Nature this week: investigation into the genetics of medulloblastoma, and more.
A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.